11.54 USD
▲-0.02+1.85%
2026-08-03
市值
$197.40M
市盈率
—
EPS
-3.43
股息率
—
52 周区间
11.13 – 16.77
成交量
136.99K
Beta
0.93
目标价
25.00
52W 低 11.1352W 高 16.77
价格走势
公司简介
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company’s development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. It has a research collaboration and license a...